Theseus Pharmaceuticals, Inc.
DelistedCIK 1745020fmd_02WQ110MKK9368EJ0AHEV3RJ80Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 15 periods
Latest annual · FY2022
Millions- Operating income
- (54)
- Net income
- (51)
- Free cash flow
- (33)
Latest quarter · Q3 FY2023
Millions- Operating income
- (16)
- Net income
- (14)
- Free cash flow
- (11)
Theseus Pharmaceuticals, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$54.1 million | -$27.3 million | 10-K 2023-03-09 · proof | |
| Net income | -$50.6 million | -$27.3 million | 10-K 2023-03-09 · proof | |
| Cash from operating activities | -$32.9 million | -$27.2 million | 10-K 2023-03-09 · proof | |
| Free cash flow | -$33.4 million | 10-K 2023-03-09 · proof | ||
| Total assets | $222.4 million | $250.9 million | -11.4% | 10-K 2023-03-09 · proof |
| Total liabilities | $14.8 million | $4.5 million | +230% | 10-K 2023-03-09 · proof |
| Cash and cash equivalents | $94.6 million | $244.7 million | -61.3% | 10-K 2023-03-09 · proof |
- What was Theseus Pharmaceuticals, Inc.'s operating income in fiscal 2022?
- Theseus Pharmaceuticals, Inc. reported operating income of -$54.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$27.3 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Theseus Pharmaceuticals, Inc.'s net income in fiscal 2022?
- Theseus Pharmaceuticals, Inc. reported net income of -$50.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$27.3 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Theseus Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2022?
- Theseus Pharmaceuticals, Inc. reported cash from operating activities of -$32.9 million for fiscal 2022 (the year ended Dec 31, 2022), against -$27.2 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Theseus Pharmaceuticals, Inc.'s free cash flow in fiscal 2022?
- Theseus Pharmaceuticals, Inc. reported free cash flow of -$33.4 million for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Theseus Pharmaceuticals, Inc.'s total assets?
- As of Dec 31, 2022, Theseus Pharmaceuticals, Inc. reported total assets of $222.4 million, against $250.9 million a year earlier (-11.4%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Theseus Pharmaceuticals, Inc.'s total liabilities?
- As of Dec 31, 2022, Theseus Pharmaceuticals, Inc. reported total liabilities of $14.8 million, against $4.5 million a year earlier (+230%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Theseus Pharmaceuticals, Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Theseus Pharmaceuticals, Inc. reported cash and cash equivalents of $94.6 million, against $244.7 million a year earlier (-61.3%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1745020&period_type=annual&limit=5"Information only, not investment advice.